A 35-year-old man, without any prior history or family history of psychosis, developed psychotic symptoms after starting with low-dose bromocriptine therapy for a macroprolactinoma. Seven days after the initiation of treatment with this medication, the patient suddenly plunged to his death in our hospital without any obvious signs. This case suggests a bromocriptine-induced very serious psychosis in which the patient killed himself without a family history and personal history of psychosis. Therefore, as for all patients with bromocriptine, their mood should be cared after, in case they might commit a suicide. We advise caution in the use of bromocriptine even in patients without a preexisting psychiatric history, and we also recommend that such changes in mental status should be monitored when bromocriptine is prescribed.
第一作者机构:[1]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;
通讯作者:
通讯机构:[3]Beijing Neurosurg Inst, Beijing 100050, Peoples R China;[4]Beijing Neurosurg Inst, 6 Tiantan Xili, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
Wang Fei,Zheng Shiqi,Zhang Yazhuo.Serious Bromocriptine-induced Psychosis: Suicide in the Treatment of Prolactinoma[J].NEUROSURGERY QUARTERLY.2013,23(4):249-251.doi:10.1097/WNQ.0b013e318275df80.
APA:
Wang, Fei,Zheng, Shiqi&Zhang, Yazhuo.(2013).Serious Bromocriptine-induced Psychosis: Suicide in the Treatment of Prolactinoma.NEUROSURGERY QUARTERLY,23,(4)
MLA:
Wang, Fei,et al."Serious Bromocriptine-induced Psychosis: Suicide in the Treatment of Prolactinoma".NEUROSURGERY QUARTERLY 23..4(2013):249-251